Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Terry Golombick PhD"'
Autor:
Terry Golombick PhD, Dipl Nut, Rajeev Ramakrishna MPH, FRACP, FRCPA, Arumugam Manoharan MD, FRACP, FRCPA
Publikováno v:
Integrative Cancer Therapies, Vol 23 (2024)
Patients with intermediate-high risk MGUS are not offered therapeutic options to date and standard of care remains observation with re-evaluations of the patient every 3 to 6 months. Given the persistent risk of progression as well as potential compl
Externí odkaz:
https://doaj.org/article/8a749059c1d746e187797159fa4206a6
Autor:
Soo Liang Ooi PhD candidate, Ron Campbell BMedSc(Hons), FRACGP, Sok Cheon Pak PhD, Terry Golombick PhD, Arumugam Manoharan MD, FRACP, FRCPA, Raj Ramakrishna MD, FRACP, FRCPA, Vladimir Badmaev MD, PhD, Janet Schloss PhD
Publikováno v:
Integrative Cancer Therapies, Vol 20 (2021)
Myelodysplastic syndrome (MDS) evolves due to genomic instability, dysregulated signaling pathways, and overproduction of inflammatory markers. Reactive oxygen species contribute to the inflammatory response, which causes gene damage, cellular remode
Externí odkaz:
https://doaj.org/article/0b8550ac2c864e7c8a06dc0b95339bc8
Autor:
Soo Liang Ooi MMath, BHSc (Comp Med), Debbie McMullen BHSc (Comp Med), Terry Golombick PhD, Dipl Nut, Sok Cheon Pak PhD
Publikováno v:
Integrative Cancer Therapies, Vol 17 (2018)
Introduction: Conventional cancer treatment, including surgery, chemotherapy, and radiotherapy, may not be sufficient to eradicate all malignant cells and prevent recurrence. Intensive treatment often leads to a depressed immune system, drug resistan
Externí odkaz:
https://doaj.org/article/c5446380702740a3a0ca99ca9ba1dfe4
Autor:
Terry Golombick PhD, Dipl, Nutr, Terrence H. Diamond MB BCh, MRCP, FRACP, Arumugam Manoharan MD, FRACP, FRCPA, Rajeev Ramakrishna BMed, FRACP, FRCPA
Publikováno v:
Integrative Cancer Therapies, Vol 16 (2017)
Clinical studies with patients with early hematological malignancies (ie, monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or stage 0/1 chronic lymphocytic leukemia) suggest that early intervention with curcumin, deriv
Externí odkaz:
https://doaj.org/article/9657270fd2ed403f9e41c443a92610df